The Presence of Antineutrophil Cytoplasmic Antibodies and Antiphospholipid Antibodies in Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A Case-Control Study among Sudanese Patients

<div>Kaplan–Meier cumulative proportion of unadjusted survival curves for SARS-CoV-2 infected individuals only (cases) between (a) those with normal and abnormal (yes) coagulation, (b) ANCA-positive and -negative patients, (c) elevated (yes) and normal levels of CRP, (d) elevated (yes) and normal levels of ESR, (e) calcium levels, and (f) presence or absence of diabetes.</div>

Interdisciplinary Perspectives on Infectious Diseases

fig3

Figure 3

Figure 3: The Presence of Antineutrophil Cytoplasmic Antibodies and Antiphospholipid Antibodies in Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A Case-Control Study among Sudanese Patients 

Figure 3 | The Presence of Antineutrophil Cytoplasmic Antibodies and Antiphospholipid Antibodies in Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A Case-Control Study among Sudanese Patients 